Answers are grounded in this paper and cite their sources.
Reveals a novel PSMA-ICG conjugate enhances prostate cancer diagnosis and management, indicating its clinical potential.
Ga]Ga-XY-PSMA-ICG is a clinically translatable dual-modality probe, offering a promising strategy to enhance the precise diagnosis and management of prostate cancer and supporting its further clinical application.
No takes yet. Share an insight, caveat, or question.
Hou et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: